MEGAN EISEL: Open Payments
NPI 1356445886 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 57 payments from 17 companies in 2025. Trend: 2023 $187 · 2024 $940 · 2025 $1,085
Food & beverage: $924Education: $161
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $183 |
| Janssen Biotech, Inc. | 5 | $159 |
| Arcutis Biotherapeutics, Inc. | 19 | $152 |
| Janssen Scientific Affairs, LLC | 1 | $150 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| UCB, Inc. | 3 | $66 |
| LEO Pharma Inc. | 1 | $52 |
| Organon LLC | 6 | $49 |
| GENZYME CORPORATION | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
Products named: TREMFYA, Zoryve, ILUMYA, Bimzelx, ANZUPGO, DUPIXENT, Rhapsido, OPZELURA.
Industry payments across IA — which companies pay providers there.
